Improved delivery through biological membranes. 4. Prodrugs of L-dopa
- PMID: 915903
- DOI: 10.1021/jm00221a014
Improved delivery through biological membranes. 4. Prodrugs of L-dopa
Abstract
Various classes of transient derivatives of L-Dopa have been synthesized, systematically protecting one or more of the main sites of metabolism in the molecule: the carboxy function, the amino, and/or the catechol system. The derivatives studied include carboxy esters, phenol esters, amides, peptides, and various combinations of these functions. A number of these derivatives effectively prevent the metabolism of L-Dopa prior to and/or during the absorption process, resulting in a significantly better bioavailability of the drug. In vivo studies using dogs showed up to 2.5-fold increase in L-Dopa blood levels. The metabolism as well as toxicity aspects of the prodrugs is also discussed.
Similar articles
-
Short-chain alkyl esters of L-dopa as prodrugs for rectal absorption.Pharm Res. 1989 Jun;6(6):501-5. doi: 10.1023/a:1015924724973. Pharm Res. 1989. PMID: 2762226
-
A new potential prodrug to improve the duration of L-dopa: L-3-(3-hydroxy-4-pivaloyloxyphenyl)alanine.J Pharm Sci. 1989 Jul;78(7):525-9. doi: 10.1002/jps.2600780703. J Pharm Sci. 1989. PMID: 2778650
-
Evaluation of rat striatal L-dopa and DA concentration after intraperitoneal administration of L-dopa prodrugs in liposomal formulations.J Control Release. 2004 Sep 30;99(2):293-300. doi: 10.1016/j.jconrel.2004.07.010. J Control Release. 2004. PMID: 15380638
-
Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).Clin Neuropharmacol. 2010 Jul;33(4):198-203. doi: 10.1097/WNF.0b013e3181de8924. Clin Neuropharmacol. 2010. PMID: 20414107 Review.
-
Novel formulations and modes of delivery of levodopa.Mov Disord. 2015 Jan;30(1):114-20. doi: 10.1002/mds.26078. Epub 2014 Dec 5. Mov Disord. 2015. PMID: 25476691 Review.
Cited by
-
Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa.Pharm Res. 1989 Jan;6(1):66-70. doi: 10.1023/a:1015855820488. Pharm Res. 1989. PMID: 2717522
-
Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.Pharm Res. 1992 Aug;9(8):969-78. doi: 10.1023/a:1015885823793. Pharm Res. 1992. PMID: 1409387 Review.
-
A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.J Dermatol. 2021 Mar;48(3):279-288. doi: 10.1111/1346-8138.15668. Epub 2021 Jan 7. J Dermatol. 2021. PMID: 33410265 Free PMC article. Clinical Trial.
-
Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs.Pharm Res. 2000 Aug;17(8):978-84. doi: 10.1023/a:1007583422634. Pharm Res. 2000. PMID: 11028945
-
Antiparkinson prodrugs.Molecules. 2008 Jan 16;13(1):46-68. doi: 10.3390/molecules13010046. Molecules. 2008. PMID: 18259129 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources